VANI NARAHARISETTY: Open Payments
NPI 1710316880 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 92 payments from 15 companies in 2025. Trend: 2023 $625 · 2024 $1,072 · 2025 $1,365
Food & beverage: $1,286Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $608 |
| Janssen Biotech, Inc. | 11 | $266 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $47 |
| Celltrion USA Inc. | 3 | $41 |
| Phathom Pharmaceuticals, Inc. | 4 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Ardelyx, Inc. | 2 | $33 |
Products named: RINVOQ, TREMFYA, CREON, SKYRIZI, DUPIXENT, ENTYVIO, LINZESS, OMVOH.
Industry payments across MS — which companies pay providers there.
